Navigation Links
Wake Forest earns patent for efficient, inexpensive fiber-based solar cells
Date:4/7/2010

Winston-Salem, N.C. -- Wake Forest University has received the first patent for a new solar cell technology that can double the energy production of today's flat cells at a fraction of the cost.

"It comes at a pretty high price to be green," said David Carroll, Ph.D., the director of Wake Forest's Center for Nanotechnology and Molecular Materials, where the fiber cell was developed. "This device can make a huge difference."

The university received the patent for fiber-based photovoltaic, or solar, cells from the European Patent Office; applications to the U.S. Patent Office are pending. The patent on the technology has been licensed to FiberCell Inc., based in the Piedmont Triad Research Park of Winston-Salem, to develop a way to manufacture the cells. The company is producing its first large test cells.

These new solar cells are made from millions of miniscule plastic fibers that can collect sunlight at oblique angles even when the sun is rising and setting. Flat-cell technology captures light primarily when the sun is directly above.

Where a flat cell loses energy when the sun's rays bounce off its shiny surface, the fiber-based design creates more surface area to confine the sun's rays, trapping the light in the tiny fiber "cans" where it bounces around until it is absorbed almost completely. That means much greater energy production with fiber-based cells: Wake Forest's fiber cells could produce about twice as many kilowatt hours per day as standard flat cells.

"We've been able to show that with a standard absorber we can collect more of the photons than anyone else can," Carroll said. "Because of the way the device works, I get more power."

To make the cells, the plastic fibers are assembled onto plastic sheets, with a technology similar to that used to create the tops of soft-drink cups. The absorber either a polymer or a dye is sprayed on. The plastic makes the cells lightweight and flexible a
'/>"/>

Contact: Ellen Sterner-Sedeno
sternersedeno@sbcglobal.net
336-758-5237
Wake Forest University
Source:Eurekalert

Page: 1 2

Related biology technology :

1. Cell Biosciences Acquires Protein Forest
2. Phenomix and Forest Laboratories to Collaborate on Development and Commercialization of Dutogliptin in Diabetes
3. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 Second Quarter Earnings
4. Oil palm plantations are no substitute for tropical rainforests, a new study shows
5. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 First Quarter Earnings
6. Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress
7. Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
8. Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
9. Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation
10. Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement
11. Forest and Cypress Announce Submission of New Drug Application for Milnacipran for the Treatment of Fibromyalgia Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Tenn. (PRWEB) December 23, 2014 Nashville ... was elected treasurer for the American Society for ... advancing knowledge and research in reproductive medicine. In ... a seat on the executive board and will have ... , Dr. Hill has actively supported ASRM since 1984 ...
(Date:12/24/2014)... -- PharmaBoardroom,s new report, , Healthcare ... for free download , digs deep into this vibrant ... the sector today. One area where ... developing a homegrown pharmaceutical manufacturing base, even if the government,s ... way off. A cursory comparison with neighboring Morocco ...
(Date:12/22/2014)... ROCKVILLE, Md. , Dec. 22, 2014 ... MKT: SYN), a developer of pathogen-specific therapies ... focus on protecting the microbiome, today announced ... a Phase 1a clinical trial of SYN-004, ... the prevention of Clostridium difficile (C. ...
(Date:12/22/2014)... December 22, 2014 The ... publication of original research, reviews and editorials addressing ... clinical practice, today published a provocative article exploring ... development, progression and potential treatment of prostate cancer. ... research and proposes the possibility that there could ...
Breaking Biology Technology:Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4
... Md., Oct. 28 Sirnaomics, Inc., (http://www.sirnaomics.com ... received an SBIR,(small business innovation research) grant ... Health (NIH). Sirnaomics, Inc., a,biopharmaceutical company founded ... interference (RNAi) Technology for novel targeted therapeutic,development. ...
... N30 Pharma (N30), a,biopharmaceutical company focused on ... nitric oxide bioavailability,announced today that it has completed ... N30 will use proceeds from this financing to ... its discovery and preclinical,research in the area of ...
... Achieves ... Collaboration Milestone, SAN DIEGO, CA - October 28, ... on using proprietary,technologies to discover and develop novel flavor ingredients for ... a payment from The Coca-Cola Company (NYSE: KO ) related ...
Cached Biology Technology:Sirnaomics Receives SBIR Grant from NCI For Its Multi-Targeted Cancer siRNA Therapeutics 2Sirnaomics Receives SBIR Grant from NCI For Its Multi-Targeted Cancer siRNA Therapeutics 3N30 Pharma Announces Financing, Expansion of Board 2SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY 2SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY 3
(Date:12/10/2014)... You,ve been here before: you desperately need to ... password, site key or the answer to your secret question. ... Today, Hoyos Labs , a digital ... finally put an end to the frustration that comes with ... 1U leverages a user,s smartphone to acquire his or her ...
(Date:12/10/2014)...  Wake Forest Baptist Medical Center today announced plans for ... Medicine. Funding for this $50 million capital project is ... publicly launched next summer. The medical ... series R.J. Reynolds Tobacco Company complex, adjacent to 525@vine ... with plans to be ready to welcome medical students ...
(Date:12/10/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ) ... Market in Japan 2014-2018" report to their ... The integration of biometrics and smart ... upgradation of the driver,s license is one of ... the aforementioned projects, biometrics is being used as ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2
... of clean green solar power may well hinge on ... the process by which green plants convert sunlight into ... Department of Energy (DOE),s Lawrence Berkeley National Laboratory (Berkeley ... recorded the first observation and characterization of a ...
... a team of researchers led by University of Notre ... in thinking about the genomics of speciation. Titled "Widespread ... today,s edition of the Proceedings of the National ... about how the genomes of newly forming species should ...
... ANN ARBOR, Mich. Researchers at the University ... radiation techniques for head and neck cancer to ... eating. A new study shows these principles and ... long-term swallowing complications. The researchers applied highly ...
Cached Biology News:Untangling the quantum entanglement behind photosynthesis 2Untangling the quantum entanglement behind photosynthesis 3Untangling the quantum entanglement behind photosynthesis 4Paper offers new insights into the genomics of speciation 2U-M study achieves reduced side effects in head and neck cancer treatment 2
Anti-MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region; rabbit host...
Mouse monoclonal [88B] to nicotinic Acetylcholine Receptor ( Abpromise for all tested applications)....
D4-GDI rabbit polyclonal antibody...
Mouse monoclonal [SPM217] to Secretory Component Glycoprotein ( Abpromise for all tested applications)....
Biology Products: